FAQ's

1. What are radiopharmaceuticals?

Radiopharmaceuticals are medical compounds that contain radioactive isotopes, used for the diagnosis or treatment of various diseases.

  • Diagnostic radiopharmaceuticals (e.g., FDG, Tc-99m compounds) help visualise organ function in PET/SPECT imaging.
  • Therapeutic radiopharmaceuticals (e.g., I-131, 177Lu, Ac-225) deliver targeted radiation to treat cancers and other conditions.
    They are produced under strict regulatory controls to ensure safety, purity, and performance.

We offer a comprehensive portfolio, including:

  • 99mTc Generators
  • I-131 Oral Solution & Capsules
  • F-18/FDG and other 18F-based radiopharmaceuticals
  • 177Lu-labelled radiopharmaceuticals
  • 99mTc cold kits
  • Peptides, Ac-225, and other radiochemical precursors
    We also operate a cyclotron facility for PET isotope production.

Yes. All products are manufactured under GMP and meet applicable national and international regulatory requirements.

Only AERB-licensed hospitals, nuclear medicine centres, radiopharmacies, and authorised distributors having a valid procurement NOC from the regulator.

Typically, 7–14 days, depending on Mo-99 activity level.

It can be eluted every 24 hours, with multiple elutions possible as activity builds.

Store in a shielded area at a controlled ambient temperature, as specified in the product guidelines.

I-131 is used for:

  • Treatment of thyroid cancer
  • Treatment of hyperthyroidism
  • Diagnostic thyroid uptake tests (where permitted)

We provide calibrated oral capsules and solutions, prepared for the required administration date.

Store in lead-shielded containers, following radiation safety and regulatory guidelines.

Common products include 177Lu-DOTATATE, 177Lu-PSMA, and custom-labelled compounds, available upon request.

Generally, 24–72 hours, depending on the compound.

Yes. GMP-grade peptides suitable for radiolabelling are available.

We offer a range including MDP, DTPA, MIBI, Sulfur Colloid, and others.

Most kits achieve >95% radiochemical purity when prepared as instructed.

18F-FDG (Fluorodeoxyglucose) is a PET radiopharmaceutical used to assess glucose metabolism, primarily for oncology, neurology, and cardiology imaging.

Yes. We manufacture F-18/FDG in-house at our cyclotron facility, ensuring consistent availability and quality.

Depending on clinical demand and regulatory approvals, we offer:

  • 18F-NaF
  • 18F-DOPA
  • 18F-PSMA
  • 18F-Flurpiridaz (if applicable)
  • Custom 18F-labelled compounds on request

Most 18F compounds have a shelf life of 6–12 hours, depending on the specific formulation.

Due to the short half-life (110 minutes), deliveries are scheduled multiple times per day according to customer imaging slots.

Yes. GMP-grade Ac-225 is available for licensed clinical and research use.

Custom requests can be supported depending on regulatory and supply feasibility.

Shipments follow IATA, AERB regulations in approved Type A or equivalent containers.

Users must follow local radiation protection standards, including shielding, contamination control, and proper waste disposal.

Yes. Technical guidance, radiolabelling support, and training can be provided.

Orders may be placed via email, assigned sales manager, or through authorised distributors.

Approximate lead times:

  • 99mTc Generator: 1–2 weeks
  • I-131: 24–48 hours
  • 177Lu: 48–72 hours
  • F-18/FDG: Daily scheduled deliveries

Support is available via email, phone, and online during business hours.